More on: Discovery of α2-plasmin inhibitor and its congenital deficiency [12]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 1, 2006, Pages 284-285

  Gallimore, Michael J ^a,b  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ALPHA 2 MACROGLOBULIN; ANTIPLASMIN; CARBOHYDRATE; CHROMOGENIC SUBSTRATE; ENZYME PRECURSOR; PLASMIN INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; ANTIFIBRINOLYTIC AGENT; PLASMINOGEN;

AFFINITY CHROMATOGRAPHY; CARBOHYDRATE ANALYSIS; CONGENITAL DISORDER; ENZYME KINETICS; FIBRINOLYSIS; GEL FILTRATION; HUMAN; IMMUNOCHEMISTRY; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; LETTER; MOLECULAR WEIGHT; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PURIFICATION; HISTORY; ISOLATION AND PURIFICATION; METABOLISM; NOTE; PHYSIOLOGY;

ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; FIBRINOLYSIS; HISTORY, 20TH CENTURY; HUMANS; PLASMINOGEN;

EID: 33644856641     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01695.x     Document Type: Letter

References (20)

1. 2-plasmin inhibitor and its congenital deficiency. J Thromb Haemost 2005; 3: 623-31.
2. Gallimore MJ, Nulkar MV, Shaw JTB. A comparative study on the inhibitors of fibrinolysis in human, dog and rabbit blood. Thromb Diath Haemorrh 1965; 14: 145-58.
3. Gallimore MJ, Shaw JTB. Some aspects of fibrin clot lysis and its inhibition by human serum. Thromb Diath Haemorrh 1967; 18; 101-13.
4. Gallimore MJ. Effect of diluents on blood clot lysis. J Clin Path 1967; 20: 234-38.
5. Gallimore MJ, Shaw JTB. The influence of various plasma components on the lysis of dilute blood clots. Thromb Diath Haemorrh 1969; 22: 223-33.
6. Gallimore MJ. The partial purification and characterisation of inter-α-antiplasmin from human serum. In: Peeters H, ed. Protides of the Biological Fluids. Proceedings of the XXIIIrd Colloquium. New York: Pergammon Press, 1975: 151-6.
7. Gallimore MJ. Serum inhibitors of fibrinolysis. Br J Haematol 1975; 31: 217-31.
8. Hedner U. Studies on an inhibitor of plasminogen activation in human serum. Thromb Diath Haemorrh 1973; 30: 414-24.
9. Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69: 209-16.
10. 2 -plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 1976; 251: 5956-65.
11. Mullertz S, Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem J 1976; 159: 545-53.
12. 2 -macroglobulin. Thromb Res 1977; 11: 267-73.
13. Hedner U, Collen D. Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma. Thromb Res 1976; 8: 875-9.
14. Gallimore MJ. Inter-α-antiplasmin: Its distinction from antiactivator. Thromb Res 1978; 12: 687-92.
15. Kruithof E, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast acting inhibitor of plasminogen-activators in human plasma. Blood 1984; 64: 907-13.
16. Wiman B, Collen D. Purification and characterisation of human antiplasmin, the fast-acting plasmin inhibitor in plasma. Eur J Biochem 1977; 78: 19-26.
17. 2-plasmin inhibitor in human plasma. Eur J Biochem 1981; 120: 105-12.
18. Teger-Nilsson AC, Friberger P, Gyzander E. determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Invest 1977; 37; 403-9.
19. Gallimore MJ, Amundsen E, Aasen AO, Larsbraaten M, Lyngaas K, Svendsen L. Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate. Thromb Res 1979; 14; 51-60.
20. Gallimore MJ, Friberger P. Chromogenic peptide substrate assays and their clinical applications. Blood Rev 1991; 5: 117-27.